Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice
Open Access
- 1 December 2021
- journal article
- research article
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 10 (6) , 796-810
Abstract
Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice Xudong Zhao, Yongsu Ma, Xiu Dong, Zhengkui Zhang, Xiaodong Tian, Xiaohang Zhao, Yinmo YangKeywords
This publication has 51 references indexed in Scilit:
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United StatesCancer Research, 2014
- Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 TrialJNCI: Journal of the National Cancer Institute, 2013
- Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in patients with pancreatic carcinoma treated with adjuvant gemcitabine-based chemotherapy after operative resectionSurgery, 2013
- Understanding Metastasis in Pancreatic Cancer: A Call for New Clinical ApproachesCell, 2012
- Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment StrategiesCell, 2012
- EMT and Dissemination Precede Pancreatic Tumor FormationCell, 2012
- Immunohistochemical Analysis of Human Equilibrative Nucleoside Transporter-1 (hENT1) Predicts Survival in Resected Pancreatic Cancer Patients Treated with Adjuvant Gemcitabine MonotherapyAnnals of Surgical Oncology, 2011
- Nucleobase Transport by Human Equilibrative Nucleoside Transporter 1 (hENT1)Journal of Biological Chemistry, 2011
- Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic CancerGastroenterology, 2009
- Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutionsScandinavian Journal of Gastroenterology, 2009